Relativity Acquisition Corp. Shareholders Approve Business Combination with Instinct Brothers

In this episode of Global Economic Press, Alex Brady discusses a significant development in the mergers and acquisitions landscape. Relativity Acquisition Corporation, a special-purpose acquisition company, has announced a major business combination with Instinct Brothers, a leader in the stem cell and regenerative medicine sector. This strategic move was approved by Relativity shareholders in an extraordinary general meeting, and the closing of the business combination is expected to occur in the coming weeks, subject to the satisfaction or waiver of all closing conditions. Upon completion, the combined company will be known as Instinct Bio Technical Company Holdings Incorporated, with its securities anticipated to be listed on Nasdaq under the symbols BIOT and BIOTW. Instinct Brothers is an integrated regenerative medicine and stem cell technology company that operates across the value chain of the stem cell cosmetic industry. The company focuses on research and development of proprietary stem cell technologies, manufacturing stem cell-derived products, and commercializing therapeutic, wellness, and skincare solutions. Relativity Acquisition Corporation, on the other hand, is a blank check company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with companies that have disruptive potential in the health, wellness, and technology sectors. For more information, visit Relativity Acquisition Corporation's website.